Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Savara Inc (SVRA)
Sector: Healthcare; Industry: Biotechnology

Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-09-20 RAMSAY DAVID A Director Buy 8,000 $1.45 $11,562 No
2022-09-08 RAMSAY DAVID A Director Buy 32,000 $1.40 $44,722 No
2022-09-01 RAMSAY DAVID A Director Buy 100,000 $1.42 $141,932 No
2021-12-30 RAMSAY DAVID A Director Buy 50,000 $1.28 $64,035 No
2021-12-17 Lowrance David L CHIEF FINANCIAL OFFICER Buy 4,000 $1.14 $4,569 No
2021-12-10 RAMSAY DAVID A Director Buy 35,000 $1.04 $36,365 No
2021-12-08 Pauls Matthew CHIEF EXECUTIVE OFFICER Buy 6,500 $1.06 $6,889 No
2021-12-02 RAMSAY DAVID A Director Buy 25,000 $1.09 $27,128 No
2021-12-02 Pauls Matthew CHIEF EXECUTIVE OFFICER Buy 10,000 $1.10 $10,954 No
2021-12-01 RAMSAY DAVID A Director Buy 25,000 $1.09 $27,157 No
2021-11-22 RAMSAY DAVID A Director Buy 200,000 $1.08 $215,393 No
2021-11-19 Pauls Matthew CHIEF EXECUTIVE OFFICER Buy 22,150 $1.10 $24,390 No
2021-09-30 RAMSAY DAVID A Director Buy 137,052 $1.29 $176,382 No
2021-08-18 Pauls Matthew CHIEF EXECUTIVE OFFICER Buy 26,900 $1.18 $31,866 No
2021-05-19 RAMSAY DAVID A Director Buy 5,003 $1.58 $7,905 No
2021-05-18 RAMSAY DAVID A Director Buy 50,000 $1.62 $81,100 No
2021-05-17 Chowdhury Badrul A. CHIEF MEDICAL OFFICER Sell 50,000 $1.56 $77,870 Yes
2021-04-19 Pauls Matthew CHIEF EXECUTIVE OFFICER Buy 27,400 $1.82 $49,871 No
2021-03-15 Lowrance David L CHIEF FINANCIAL OFFICER Buy 13,793 $1.45 $20,000 No
2021-02-22 Pauls Matthew CHIEF EXECUTIVE OFFICER Buy 28,700 $1.74 $50,038 No
2019-06-28 RAMSAY DAVID A Director Buy 58,357 $2.37 $138,225 No
2019-04-08 Jouhikainen Jaakko Taneli President and COO Sell 25,000 $9.03 $225,665 No
2018-11-01 Lowrance David L Chief Financial Officer Sell 18,480 $9.22 $170,476 No
2018-06-12 Neville Robert N Chief Executive Officer Sell 17,973 $12.09 $217,312 Yes
2018-06-12 Lowrance David L Chief Financial Officer Sell 5,275 $12.08 $63,727 No
2018-06-12 Jouhikainen Jaakko Taneli nan Sell 17,757 $12.10 $214,789 No
2018-03-29 PIKOVER YURI Director Buy 3,734 $9.00 $33,603 No
2018-02-15 Neville Robert N Chief Executive Officer Sell 25,000 $12.93 $323,173 No
2018-02-15 Lowrance David L Chief Financial Officer Sell 7,000 $12.88 $90,129 Yes
2017-10-27 PIKOVER YURI Director Buy 50,000 $7.85 $392,500 No

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?